These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 29546928)
41. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation. dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454 [TBL] [Abstract][Full Text] [Related]
42. Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review. Siegel M; Timpone J Clin Infect Dis; 2001 Mar; 32(6):972-4. PubMed ID: 11247720 [TBL] [Abstract][Full Text] [Related]
43. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). Nuorti JP; Whitney CG; MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868 [TBL] [Abstract][Full Text] [Related]
44. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated in Japan after introduction of the routine immunization program. Miyazaki H; Shibuya R; Midorikawa N; Chang B; Ohnishi M; Matsumoto T J Infect Chemother; 2017 Apr; 23(4):234-240. PubMed ID: 28161295 [TBL] [Abstract][Full Text] [Related]
45. Latent infective endocarditis: epidemiology and clinical characteristics of patients with unsuspected endocarditis detected after elective valve replacement. Shapira N; Merin O; Rosenmann E; Dzigivker I; Bitran D; Yinnon AM; Silberman S Ann Thorac Surg; 2004 Nov; 78(5):1623-9. PubMed ID: 15511445 [TBL] [Abstract][Full Text] [Related]
46. Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands. Wagenvoort GH; Sanders EA; Vlaminckx BJ; Elberse KE; de Melker HE; van der Ende A; Knol MJ Vaccine; 2016 Feb; 34(8):1077-85. PubMed ID: 26778420 [TBL] [Abstract][Full Text] [Related]